Czarnetzki B, Konig W, Lichtenstein L
Inflammation. 2013; 1(2):201-15.
PMID: 24194429
DOI: 10.1007/BF00917530.
Shindo K, Koide K, Hirai Y, Sumitomo M, Fukumura M
Thorax. 1996; 51(2):155-8.
PMID: 8711647
PMC: 473025.
DOI: 10.1136/thx.51.2.155.
Portmann P, Koppel P, Jorg A
Experientia. 1980; 36(1):139-41.
PMID: 7358123
DOI: 10.1007/BF02004024.
GARTNER I
Immunology. 1980; 40(1):133-6.
PMID: 6252099
PMC: 1458478.
Parish W
Immunology. 1972; 23(1):19-34.
PMID: 5045232
PMC: 1407764.
Production of a rabbit antimouse eosinophil serum with no cross-reactivity to neutrophils.
Mahmoud A, Warren K, Boros D
J Exp Med. 1973; 137(6):1526-31.
PMID: 4709271
PMC: 2139341.
DOI: 10.1084/jem.137.6.1526.
Leukocyte locomotion and chemotaxis. New methods for evaluation, and demonstration of a cell-derived chemotactic factor.
Zigmond S, Hirsch J
J Exp Med. 1973; 137(2):387-410.
PMID: 4568301
PMC: 2139498.
DOI: 10.1084/jem.137.2.387.
Formation of slow-reacting substance of anaphylaxis in human lung tissue and cells before release.
Lewis R, Wasserman S, Goetzi E, Austen K
J Exp Med. 1974; 140(5):1133-46.
PMID: 4378429
PMC: 2139726.
DOI: 10.1084/jem.140.5.1133.
Enhancement of random migration and chemotactic response of human leukocytes by ascorbic acid.
Goetzl E, Wasserman S, Gigli I, Austen K
J Clin Invest. 1974; 53(3):813-8.
PMID: 4273024
PMC: 333062.
DOI: 10.1172/JCI107620.
Modulation of the immunological release of the eosinophil chemotactic factor of anaphylaxis from human lung.
Wasserman S, Goetzl E, Kaliner M, Austen K
Immunology. 1974; 26(4):677-84.
PMID: 4137063
PMC: 1423172.
Purification of eosinophils from normal human blood, preparation of eosinoplasts and characterization of their functional response to various stimuli.
Yazdanbakhsh M, Eckmann C, de Boer M, Roos D
Immunology. 1987; 60(1):123-9.
PMID: 3817866
PMC: 1453348.
A rapid method for the preparation of the neutrophil fraction of granulocytes from human blood by centrifugation on isotonic Nycodenz gradients.
Ford T, Needle R, Rickwood D
Blut. 1987; 54(6):337-42.
PMID: 3593982
DOI: 10.1007/BF00626014.
Eosinophils. Assays and interpretation.
Maddox D
Clin Rev Allergy. 1988; 6(2):163-90.
PMID: 3048625
Isolation and partial characterization of human eosinophil granules. Comparison to neutrophils.
West B, Gelb N, Rosenthal A
Am J Pathol. 1975; 81(3):575-88.
PMID: 1211424
PMC: 2032331.
Purification and synthesis of eosinophilotactic tetrapeptides of human lung tissue: identification as eosinophil chemotactic factor of anaphylaxis.
Goetzl E, Austen K
Proc Natl Acad Sci U S A. 1975; 72(10):4123-7.
PMID: 1060093
PMC: 433151.
DOI: 10.1073/pnas.72.10.4123.
Comparative properties of the Charcot-Leyden crystal protein and the major basic protein from human eosinophils.
Gleich G, Loegering D, Mann K, Maldonado J
J Clin Invest. 1976; 57(3):633-40.
PMID: 942977
PMC: 436696.
DOI: 10.1172/JCI108319.
Purification of normal human eosinophils using the different binding capacities of blood leucocytes for complexed rabbit IgG.
Tai P, Spry C
Clin Exp Immunol. 1977; 28(2):256-60.
PMID: 872450
PMC: 1540766.
Isolation of human eosinophils and their lymphocyte-like rosetting properties.
SHER R, Glover A
Immunology. 1976; 31(3):337-41.
PMID: 800403
PMC: 1445251.
Extracellular release of peroxidase from eosinophils by interaction with immune complexes.
Takenaka T, Okuda M, Kawabori S, Kubo K
Clin Exp Immunol. 1977; 28(1):56-60.
PMID: 301076
PMC: 1540880.
Anaphylactic relase of a basophil kallikrein-like activity. II. A mediator of immediate hypersensitivity reactions.
Newball H, TALAMO R, Lichtenstein L
J Clin Invest. 1979; 64(2):466-75.
PMID: 222810
PMC: 372141.
DOI: 10.1172/JCI109484.
